{ "module": "kr-companies", "itemId": "00828497", "title": "Hanmi Pharm. Co., Ltd. (한미약품(주)) — KOSPI 128940", "summary": "Korean listed company (한미약품(주), KOSPI 128940). Official DART corporate profile, KRW financial summary, and recent filings.", "data": { "corp_code": "00828497", "stock_code": "128940", "name_en": "Hanmi Pharm. Co., Ltd.", "name_ko": "한미약품(주)", "alternate_names": [ "한미약품" ], "market": "KOSPI", "ceo_name": "황상연", "business_registration_no": "1248700613", "corporate_registration_no": "1348110197550", "address": "경기도 화성시 팔탄면 무하로 214", "homepage": null, "established_date": "2010-07-05", "fiscal_month": "12", "industry_code": "21212", "financials": { "fiscal_year": 2025, "basis": "CFS", "currency": "KRW", "revenue": 1547531098763, "operating_income": 257799090185, "net_income": 187135533539, "total_assets": 2137597680857, "total_liabilities": 714744458123, "total_equity": 1422853222734, "prior_year": { "fiscal_year": 2024, "revenue": 1495501575568, "operating_income": 216186188006, "net_income": 140431062099, "total_assets": 2020840493653, "total_liabilities": 780088902015, "total_equity": 1240751591638 }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001130", "verified_at": "2026-11-01T02:28:16.948Z" }, "recent_filings": [ { "receipt_no": "20261030800861", "filed_date": "2026-10-30", "title_ko": "기업설명회(IR)개최(안내공시)", "title_en": "Organization of Investor Relations Event", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800861" }, { "receipt_no": "20261030800002", "filed_date": "2026-10-30", "title_ko": "투자판단관련주요경영사항 (파브리병 치료제(LAGLA) 기술이전 계약 체결)", "title_en": "Material Business Matters Related to Investment Decisions (파브리병 치료제(LAGLA) 기술이전 계약 체결)", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800002" }, { "receipt_no": "20261027800662", "filed_date": "2026-10-27", "title_ko": "주식소각결정", "title_en": "Retirement of Stocks", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261027800662" }, { "receipt_no": "20261027800461", "filed_date": "2026-10-27", "title_ko": "연결재무제표기준영업(잠정)실적(공정공시)", "title_en": "Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261027800461" }, { "receipt_no": "20261016800703", "filed_date": "2026-10-16", "title_ko": "기업설명회(IR)개최(안내공시)", "title_en": "Organization of Investor Relations Event", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261016800703" }, { "receipt_no": "20261016800700", "filed_date": "2026-10-16", "title_ko": "결산실적공시예고(안내공시)", "title_en": "Prior Notice on Disclosure of Final Earnings", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261016800700" }, { "receipt_no": "20261007800667", "filed_date": "2026-10-07", "title_ko": "투자판단관련주요경영사항 (에페오토인젝터주(에페글레나타이드) 식품의약품안전처 품목허가 승인)", "title_en": "Material Business Matters Related to Investment Decisions (에페오토인젝터주(에페글레나타이드) 식품의약품안전처 품목허가 승인)", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261007800667" }, { "receipt_no": "20261006000230", "filed_date": "2026-10-06", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "국민연금공단", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261006000230" }, { "receipt_no": "20261002000501", "filed_date": "2026-10-02", "title_ko": "주식등의대량보유상황보고서(약식)", "title_en": "Report on significant holdings of stocks, etc. (Short form)", "filer": "국민연금공단", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261002000501" }, { "receipt_no": "20260929800978", "filed_date": "2026-09-29", "title_ko": "투자판단관련주요경영사항", "title_en": "Material Business Matters Related to Investment Decisions", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260929800978" }, { "receipt_no": "20260929000668", "filed_date": "2026-09-29", "title_ko": "주식등의대량보유상황보고서(일반)", "title_en": "Report on significant holdings of stocks, etc. (General)", "filer": "한미사이언스", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260929000668" }, { "receipt_no": "20260929000085", "filed_date": "2026-09-29", "title_ko": "임원ㆍ주요주주특정증권등소유상황보고서", "title_en": "Report on status of specific securities, etc. owned by executives and major shareholders", "filer": "국민연금공단", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260929000085" }, { "receipt_no": "20260908800596", "filed_date": "2026-09-08", "title_ko": "기업설명회(IR)개최(안내공시)", "title_en": "Organization of Investor Relations Event", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260908800596" }, { "receipt_no": "20260908800550", "filed_date": "2026-09-08", "title_ko": "최대주주등소유주식변동신고서", "title_en": "Report on Shares Change of Largest Shareholders", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260908800550" }, { "receipt_no": "20260908000370", "filed_date": "2026-09-08", "title_ko": "주식등의대량보유상황보고서(일반)", "title_en": "Report on significant holdings of stocks, etc. (General)", "filer": "한미사이언스", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260908000370" }, { "receipt_no": "20260828800615", "filed_date": "2026-08-28", "title_ko": "최대주주등소유주식변동신고서", "title_en": "Report on Shares Change of Largest Shareholders", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260828800615" }, { "receipt_no": "20260826800466", "filed_date": "2026-08-26", "title_ko": "[기재정정]투자판단관련주요경영사항 (급성골수성백혈병(AML) 치료 항암신약 HM43239 기술이전 계약 체결)", "title_en": "[Corrected description]Material Business Matters Related to Investment Decisions (급성골수성백혈병(AML) 치료 항암신약 HM43239 기술이전 계약 체결)", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260826800466" }, { "receipt_no": "20260824800144", "filed_date": "2026-08-24", "title_ko": "투자판단관련주요경영사항", "title_en": "Material Business Matters Related to Investment Decisions", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260824800144" }, { "receipt_no": "20260821800930", "filed_date": "2026-08-21", "title_ko": "[기재정정]투자판단관련주요경영사항", "title_en": "[Corrected description]Material Business Matters Related to Investment Decisions", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260821800930" }, { "receipt_no": "20260821800876", "filed_date": "2026-08-21", "title_ko": "[기재정정]투자판단관련주요경영사항", "title_en": "[Corrected description]Material Business Matters Related to Investment Decisions", "filer": "한미약품", "url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260821800876" } ], "source_urls": { "company": "https://dart.fss.or.kr", "financials": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001130", "filings": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261030800861" }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001130", "verified_at": "2026-11-01T02:25:50.561Z", "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company." }, "source_url": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001130", "verified_at": "2026-11-01T02:25:50.561Z", "updated_at": "2026-11-01T02:25:50.561Z", "notice": "Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company." }